Logotype for Seer Inc

Seer (SEER) investor relations material

Seer Morgan Stanley 23rd Annual Global Healthcare Conference summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Seer Inc
Morgan Stanley 23rd Annual Global Healthcare Conference summary9 Sep, 2025

Product innovation and platform evolution

  • Released third-generation Proteograph One in June 2025, enabling large-scale, unbiased proteomics at improved speed and cost.

  • Proteograph One doubles throughput to 1,000 samples per week and reduces runtime by 30% compared to XT.

  • New SP200 instrument and Proteograph Direct Assay introduced, offering end-to-end proprietary workflow and automation for both complex and less complex samples.

  • Workflow improvements include halved MassTech time, reduced manual steps, and better cost efficiency, leading to higher margins.

  • Direct Assay broadens instrument utility, allowing cell and tissue analysis without proprietary particles, addressing customer needs for automation.

Market adoption and customer trends

  • Shift from small proof-of-principle studies to immediate large-scale adoption, with customers now starting with thousands of samples.

  • Announced major studies: 10,000-sample corporate study, 20,000-sample Korea University study, and a 10,000-sample pilot with a biobank aiming for 100,000 samples.

  • Customers value reproducibility, robustness, and scalability for longitudinal and multi-site studies, leading to selection over competitors.

  • Comparative studies published by customers highlight superior performance over lower-cost, me-too platforms.

  • Expectation that population-scale studies will become more common, with 2026 predicted as the year for the first 100,000-sample unbiased proteomics study.

Competitive landscape and differentiation

  • Proteomics market divided into targeted (e.g., OLINK, SomaLogic) and untargeted approaches, with Seer positioned as a leader in untargeted, large-scale discovery.

  • Targeted and untargeted platforms seen as complementary; untargeted needed for discovery, targeted for clinical applications.

  • Me-too nanoparticle-based platforms lack depth, reproducibility, and robustness, causing customer confusion but not real competition.

  • Customers prioritize data quality and sample value over lower assay costs, especially in high-value biopharma applications.

  • Future differentiation will depend on ability to deliver from discovery to clinical, with untargeted approaches driving innovation.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Seer earnings date

Logotype for Seer Inc
Q3 20255 Nov, 2025
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Seer earnings date

Logotype for Seer Inc
Q3 20255 Nov, 2025

The essential earnings season companion

The #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Seer Inc develops life sciences technologies intended to enable discovery of proteomic biomarkers with high throughput and precision. The company’s products support research in areas such as biomarker identification, disease detection, and therapeutic development. Seer serves pharmaceutical, academic, and research institutions in the life sciences sector. The company is headquartered in Redwood City, California, and its shares are listed on the NASDAQ.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage